Today we look at 2 months of Colombia’s National Strike, the release of activists Samar Badawi and Nassima al-Sadah from prison in Saudi Arabia, and more
Two new vaccines, both developed in Cuba, have shown remarkable efficacy in clinical trials. It is crucial to remember that Cuba developed these vaccines even as it continues to suffer under the crippling blockade imposed by the US.
The Abdala vaccine showed 92.28% efficacy with three doses during the third phase of clinical trials and the Soberana 02 vaccine showed 62% efficacy with just two of its three doses
In previous trials, the Soberana 02 vaccine candidate generated antibody response in about 80% of the people who were administered two doses